Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Should I Buy BUD Stock? 3 Pros, 3 Cons

By Will Ashworth, InvestorPlace Contributor

BUD stock is up on the news that Anheuser-Busch InBev is buying the biggest brewer in South Korea. Does that make BUD stock a buy? Here are 3 pros and cons.

AAPL – 3 Reasons Apple Stock Is a Buy Despite Downgrades

By Will Ashworth, InvestorPlace Contributor

A few downgrades have some investors wondering if it's time to sell Apple stock. Don't. With record earnings, 2014 will be a bounce-back year for AAPL.

3 Small Caps That Are Ready to Rebound

By Will Ashworth, InvestorPlace Contributor

In what could be a weaker year for most small caps, investors might be best served by looking at 2013's laggards.

Can Watson Power IBM Stock to New Highs?

By Will Ashworth, InvestorPlace Contributor

Watson the supercomputer is getting its own home in New York City. IBM (IBM) announced on Jan. 9 that it’s creating a separate business unit…

UnitedHealth Earnings: Is UNH Stock a Buy After Earnings?

By Will Ashworth, InvestorPlace Contributor

UnitedHealth Group delivered solid Q4 earnings Thursday, beating the EPS estimate by a penny. But does its 2014 guidance make UNH stock a buy or sell?

Load More